MGMT and glioma: In recent years, significant success has been achieved in the use of biomarkers in the diagnosis of central nervous system (CNS) tumors, which are already used in everyday medical practice, such as methylation in promoter O6-methylguanine-DNA-methyltransferase (MGMT) gene in gliomas [34].